WO2022258404A1 - Topical composition for restoring microbial diversity of scalp - Google Patents
Topical composition for restoring microbial diversity of scalp Download PDFInfo
- Publication number
- WO2022258404A1 WO2022258404A1 PCT/EP2022/064510 EP2022064510W WO2022258404A1 WO 2022258404 A1 WO2022258404 A1 WO 2022258404A1 EP 2022064510 W EP2022064510 W EP 2022064510W WO 2022258404 A1 WO2022258404 A1 WO 2022258404A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- scalp
- dandruff
- composition
- diversity
- restoring
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 108
- 210000004761 scalp Anatomy 0.000 title claims abstract description 87
- 230000000699 topical effect Effects 0.000 title claims abstract description 20
- 230000000813 microbial effect Effects 0.000 title description 10
- 208000001840 Dandruff Diseases 0.000 claims abstract description 65
- 241000736262 Microbiota Species 0.000 claims abstract description 41
- -1 piroctone compound Chemical class 0.000 claims abstract description 25
- 229950001046 piroctone Drugs 0.000 claims abstract description 23
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 claims description 25
- 229940081510 piroctone olamine Drugs 0.000 claims description 19
- 241000894006 Bacteria Species 0.000 claims description 18
- 239000002537 cosmetic Substances 0.000 claims description 11
- 241000233866 Fungi Species 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 241000894007 species Species 0.000 description 25
- 239000002453 shampoo Substances 0.000 description 21
- 244000005700 microbiome Species 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 16
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 10
- 229920002125 Sokalan® Polymers 0.000 description 10
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 8
- 241000282414 Homo sapiens Species 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 230000002538 fungal effect Effects 0.000 description 6
- 125000002252 acyl group Chemical group 0.000 description 5
- 239000003945 anionic surfactant Substances 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 150000008051 alkyl sulfates Chemical class 0.000 description 4
- 230000036074 healthy skin Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 239000000375 suspending agent Substances 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical class NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- 208000027244 Dysbiosis Diseases 0.000 description 3
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 3
- 241000555676 Malassezia Species 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- OPVLOHUACNWTQT-UHFFFAOYSA-N azane;2-dodecoxyethyl hydrogen sulfate Chemical compound N.CCCCCCCCCCCCOCCOS(O)(=O)=O OPVLOHUACNWTQT-UHFFFAOYSA-N 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 230000007140 dysbiosis Effects 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 241000928573 Cutibacterium Species 0.000 description 2
- 206010012438 Dermatitis atopic Diseases 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001291477 Malassezia restricta Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241001147736 Staphylococcus capitis Species 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 2
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- OIQJEQLSYJSNDS-UHFFFAOYSA-N piroctone Chemical compound CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O OIQJEQLSYJSNDS-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229940057950 sodium laureth sulfate Drugs 0.000 description 2
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BTMZHHCFEOXAAN-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;2-dodecylbenzenesulfonic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O BTMZHHCFEOXAAN-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- VFKZECOCJCGZQK-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCO VFKZECOCJCGZQK-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000555688 Malassezia furfur Species 0.000 description 1
- 241001291474 Malassezia globosa Species 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- ZWXYEWJNBYQXLK-UHFFFAOYSA-N azanium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [NH4+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O ZWXYEWJNBYQXLK-UHFFFAOYSA-N 0.000 description 1
- 230000037365 barrier function of the epidermis Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940080421 coco glucoside Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000009215 host defense mechanism Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
- HFQQZARZPUDIFP-UHFFFAOYSA-M sodium;2-dodecylbenzenesulfonate Chemical compound [Na+].CCCCCCCCCCCCC1=CC=CC=C1S([O-])(=O)=O HFQQZARZPUDIFP-UHFFFAOYSA-M 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 229940105956 tea-dodecylbenzenesulfonate Drugs 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
Definitions
- the present invention relates to a method of restoring microbial diversity of scalp, which is dandruff scalp.
- the skin is the largest organ of human body. It protects our body from external factors such as the environment, pollution and microbes. Our skin harbours a diverse range of microorganisms which live as a community and function as a component of skin biology. Due to the advent of next-generation sequencing technologies, we now know that the microbiome or microbiota of human skin is highly dependent on biophysical characteristics and chemical constitution of the skin. For example, sebaceous sites are dominated by Cutibacterium sp., whereas moist areas harbour Staphylococcus and Corynebacterium species. Any adverse alteration in the microbiome of our skin (dysbiosis) could lead to conditions, that may need at least cosmetic treatment as such seen in the case of acne, dry skin and dandruff.
- Dandruff a skin disorder common among many people globally. The condition is manifested by the shedding of clumps of dead skin cells from the scalp. It is known that microbiome dysbiosis, increased sebum production and inflammation are the most common contributing factors.
- Staphylococcus epidermidis and Staphylococcus capitis.
- Staphylococcus is one of the most abundant genera across both healthy and dandruff scalps. However, at species level, Staphylococcus capitis is reported to be positively associated with dandruff conditions, while Staphylococcus epidermidis is positively associated with non-dandruff scalp conditions.
- dandruff is associated with an altered microbiota involving multiple taxa, as evidenced by an increase in the abundance of certain microbes and a concomitant decrease in the abundance of some others.
- Such an imbalance often manifests itself as a dysbiotic condition like acne or dandruff.
- Other such dysbiotic conditions include atopic dermatitis and dry skin.
- such conditions can be managed by cosmetic treatment by the application of topical compositions that contain one or more active ingredients.
- the microbiome of skin can be balanced e.g. by reducing the overall microbial load of skin or by selectively reducing some while selectively increasing the count of some others.
- balancing the microbiota of skin refers to selectively increasing the microbial count of good microbes and/or reducing the same count of bad microbes.
- Good microbes are said to provide benefit to their host through e.g., competing with bad microbes for available nutrients and through secretion of good metabolites.
- a bacterial/fungal community is characterized by the number of species present therein and their absolute numbers. This is called bacterial/fungal diversity.
- Shannon-Weaver or simply Shannon
- Simpson’s diversity index are commonly used in such measurements based on Operational Taxonomic Units (OTUs).
- OTUs can be defined at different levels of resolution such as phylum, class, order, family, genus, and species).
- ACE Abundance-based Coverage Estimator
- Chaol indices are used to estimate richness (estimated richness; measurement of OTUs expected in samples given all the bacterial species that were identified in the samples).
- Biological diversity means the variability among living organisms from the ecological complexes of which organisms are part, and it is defined as species richness and relative species abundance in space and time.
- a measure of the number of different kinds of organisms present in a community is defined as richness, therefore richness refers to the number of different species present in a certain niche. If more species are present in “A” than “B”, “A” is richer than “B”. When it comes to species richness, it does not consider the number of individuals of each species present. Diversity is not only based on richness, but also evenness. Evenness compares the uniformity of the population size of each of the species present.
- a measure of the relative abundance of the different species consisting of a community is evenness. In general, when species richness and evenness increase, diversity also increases.
- XP055874533 discloses anti-dandruff composition comprising piroctone olamine as active agent against dandruff and for fighting microorganisms causing dandruff. However, it does not disclose the impact of piroctone olamine on the diversity of microbiota of scalp.
- EP3695825 A1 discloses a hair care composition against dandruff comprising piroctone olamine. It discloses that piroctone olamine is able to decrease the level of Malassezia species. However, it does not disclose the impact of piroctone olamine on the diversity of microbiota of scalp.
- WO2013093823 A2 discloses oil compositions comprising at least 0.01wt% piroctone olamine exhibiting antifungal activity against Malassezia furfur useful as anti-dandruff agent. However, it does not disclose the impact of piroctone olamine on the diversity of microbiota of scalp.
- US2016058775 A1 discloses hair care compositions comprising at least 0.01% of piroctone olamine exhibiting antifungal (Malassezia species) and antibacterial activity. However, it does not disclose the impact of piroctone olamine on the diversity of microbiota of scalp.
- JPH10265408 A discloses a lotion for atopic dermatitis comprising at least 0.01 % of a piroctone compound. However, it does not disclose the impact of piroctone olamine on the diversity of microbiota of scalp.
- US10071103 B2 (VYOME BIOSCIENCES PVT LTD) relates generally to novel molecules compositions and formulations for treatment of bacterial infections in general and more specifically to bacterial infections with antibiotic-tolerant pathogens. It does not disclose the use of piroctone compound for restoring diversity of microbiota of dandruff scalp.
- US2019000734 A1 (STURGIS DAVID ARTHUR ET AL) relates to antiperspirant and deodorant compositions and methods relating thereto. It does not disclose the use of piroctone compound for restoring diversity of microbiota of dandruff scalp. Summary of the Invention
- a piroctone compound in a topical composition for restoring diversity of microbiota of scalp having dandruff to a level normally indicative of healthy scalp; further wherein the richness of microbes of scalp having dandruff after restoring is improved to a level normally indicated of healthy scalp.
- a method of restoring diversity of microbiota of scalp having dandruff to a level normally indicative of healthy scalp comprising a step of applying thereto a piroctone compound in a topical composition.
- a topical composition comprising a piroctone compound for use in restoring diversity of microbiota of scalp having dandruff to a level normally indicative of healthy scalp; further wherein the richness of microbes of scalp having dandruff after restoring is improved to a level normally indicated of healthy scalp.
- a piroctone compound for restoring diversity of microbiota of scalp having dandruff to a level normally indicative of healthy scalp; further wherein the richness of microbes of scalp having dandruff after restoring is improved to a level normally indicated of healthy scalp.
- Figure 1 shows the Beta diversity of bacteria of dandruff-subjects as compared to non dandruff subjects before and after treatment.
- Figure 2 shows the Beta diversity of fungi of dandruff-subjects as compared to non dandruff subjects before and after treatment.
- a cosmetic composition as used herein, is meant to include a composition for topical application to skin, hair and/or scalp of mammals, especially human beings. Such a composition is generally applied on to the desired topical surface of the body for a period of time from a few seconds to up to 24 hours. When the period of time of application is low say of the order of a few seconds to a few minutes after which the composition is rinsed off with water or wiped away, such a composition is known as a cleansing composition or a wash-off composition. On the other hand, When the composition is applied for longer period of time say from several minutes to up to 24 hours and washed off usually during the process of normal personal cleaning, such a composition is known as a leave-on composition.
- the composition as per the present invention includes any product applied to a human body for also improving appearance, cleansing, odor control or general aesthetics.
- hair care composition is meant to include a composition for topical application to hair or scalp of mammals, especially humans.
- topical is meant that the composition is applied to the external surface of the body. In the present invention this is achieved by applying the composition on the hair or scalp.
- Such a composition may be generally classified as leave-on or rinse off, and includes any product applied for improving the appearance, cleansing, odor control or general aesthetics of scalp and hair.
- the hair care composition of the present invention could be in the form of a liquid, lotion, cream, foam, scrub, gel, shampoo, conditioner, shower gel or bar.
- the haircare composition of the present invention is preferably a leave-on composition.
- the hair care composition of the present invention is a wash-off composition. Compositions for achieving the desired benefits by way of ingestion into the human body are excluded from the scope of the present invention.
- Restoring the microbiota diversity used herein preferably means restoring the alpha diversity of microbiota which means increasing or decreasing the number of different types of microbes and/or the evenness of the different types of microbes in the microbiota of a subject.
- the microbiota diversity is increased.
- the number of different genera of bacteria in the microbiota is increased.
- the number of different species of bacteria in the microbiota is increased.
- the number of different strains of bacteria in the microbiota is increased.
- the microbiota diversity is decreased.
- the number of different genera of bacteria in the microbiota is decreased.
- the number of different species of bacteria in the microbiota is decreased. In some embodiments, the number of different strains of bacteria in the microbiota is decreased. In some embodiments, the number of genera, species and strains in the microbiota is restored.
- Restoring the microbiota diversity used herein alternatively means restoring the beta diversity of microbiota which means the similarity of a community of microbes in the microbiota of a subject.
- Beta diversity is a measure of the difference in microbial composition between two samples or groups of samples based on taxonomic abundance, presence or absence, or on phylogenetic distances. Samples or groups of samples that are similar to each other have a low variation in beta diversity where samples or groups of samples that are different to each other have high variation in beta diversity.
- “Amenable skin” means scalp which has dandruff.
- the term “normal healthy skin” preferably refers to skin which is free from any infection.
- healthy scalp preferably refers to scalp which is free from dandruff. Chad is Abundance-based estimator of species richness where F1 and F2 are the count of singletons and doubletons, respectively, and S obs is the number of observed species.
- Chad is a nonparametric method for estimating the number of species in a community.
- the Chad richness estimator was developed by Anne Chao and is based on the concept that rare species infer the most information about the number of missing species. Because the Chad richness estimator gives more weight to the low abundance species, only the singletons and doubletons are used to estimate the number of missing species. Therefore, this index is particularly useful for data sets skewed toward the low-abundance species.
- a microbe can be described as a tiny living organism, such as bacterium, fungus, or virus.
- a microbiome or microbiota refers collectively to all the microbes on or in the human body. In other words, a microbiome is a community of microbes.
- a balanced microbiota containing an appropriate diversity of organisms helps to maintain health and is essential for human development, immunity, health and wellbeing.
- Each of our individual microbiomes adapts throughout our lifetime and people can achieve a healthy microbiome in different ways.
- lAmenable skin means the scalp having dandruff.
- Dandruff is a common scalp condition, characterized by excessive flaking and itch. It is generally accepted that the presence of dandruff is associated with changes in microbe ecology, altered lipid composition, inflammation and abnormal epidermal barrier function.
- the Malassezia yeast has long been considered as one of the main microbial drivers for dandruff. Severity of dandruff is generally associated with an increased abundance of Malassezia restricta. In addition, a trend towards an increase in the relative proportions of Staphylococcus to Cutibacterium is observed as dandruff scores increase, suggesting an imbalanced microbial ecology in the dandruff-affected scalp.
- the microbes are bacteria or fungi, more preferably bacteria.
- the microbes are protozoans or viruses. Without wishing to be bound by theory it is believed that balanced microbiota of scalp having dandruff, is a result of a piroctone compound in the topical composition with the host defense mechanism.
- restoring diversity of microbiota of scalp having dandruff includes restoring alpha diversity, determined using an alpha diversity index.
- the richness of microbes of scalp having dandruff is improved to the level normally indicative of healthy scalp.
- the alpha diversity measures include at least one of Shannon Index, Chad, Observed OTUs, ACE, Simpson or Fisher, more preferably Chad which indicates the richness of microbes of scalp.
- the alpha diversity index as represented by Chad index of the scalp having dandruff after restoring is increased to a level normally indicated of healthy scalp.
- the diversity is determined using a beta diversity index. It is preferred that the beta diversity of the scalp having dandruff is restored to a level normally indicative of healthy scalp. More preferably the beta diversity measures includes Bray-Curtis dissimilarity, Jaccard distance or and weighted/unweighted UniFrac.
- the topical composition comprises 0.001 to 5.0 wt% of a piroctone compound.
- the composition comprises a piroctone compound, it preferably comprises 0.01 to 5%, more preferably 0.05 to 2%, still more preferably 0.5 to 1% of piroctone compound by weight of the total composition.
- the piroctone compound is piroctone olamine.
- Piroctone Olamine is an olamine salt of the hydroxamic acid derivative piroctone. It is commonly known as piroctone ethanolamine with the trade name Octopirox ® .
- the piroctone olamine according to the present invention is a 1:1 compound of 1- hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2(1H)-pyridinone with 2-aminoethanol and is also designated 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2(1H) pyridinone monoethanolamine salt.
- the CAS number is 68890-66-4 and the compound has the general formula (II) as below:
- the composition comprises piroctone olamine it preferably comprises 0.01 to 5%, more preferably 0.05 to 2%, still more preferably 0.5 to 1% of piroctone olamine by weight of the total composition.
- the topical composition is a cosmetic composition.
- the topical composition is a medicament or a pharmaceutical composition.
- the cosmetic composition is preferably in the form of a wash-off or a leave-on composition, more preferably a wash-off composition.
- a wash-off cosmetic composition more preferably a hair care composition comprising 0.01 to 5.0 wt% of a piroctone compound.
- Leave-on composition preferably means a composition which is not required to be removed or washed off from the human body after the application of the composition.
- the composition is preferably a deodorant (stick, roll-on or spray), a hand sanitizer, a body lotion, a skin cream or body spray.
- Leave-on compositions are to be distinguished from compositions which are applied to the skin and subsequently removed, either by washing, rinsing, wiping, or the like either soon after or during the application of the product.
- wash-off composition preferably means a composition which is intended/required to be removed from the body by washing with solvent preferably water after the application of said composition like e.g. a shampoo, a hand wash composition and a face wash composition.
- solvent preferably water after the application of said composition like e.g. a shampoo, a hand wash composition and a face wash composition.
- a cosmetically acceptable base preferably further comprises a surfactant.
- the cosmetically acceptable base preferably comprises an anionic surfactant e.g. an alkyl sulphate and/or ethoxylated alkyl sulfate surfactant.
- anionic surfactants are preferably present at a level of from 1 to 20 wt%, more preferably from 2 to 16 wt%, even more preferably from 3 to 16 wt%.
- Preferred alkyl sulfates are C8 to 18 alkyl sulfates, more preferably C12 to 18 alkyl sulfates, preferably in the form of a salt with a solubilizing cation such as sodium, potassium, ammonium or substituted ammonium.
- the topical composition comprises a cosmetically acceptable base.
- ingredients that may be used as cosmetically acceptable base includes water, fatty acids, soaps (salts of fatty acids), alcohols and mixtures thereof.
- the composition for use in the invention is a hair care composition
- it preferably is a wash-off composition, especially shampoo or a conditioner.
- the preferred use of the cosmetic composition is in a shampoo.
- the cosmetic composition may suitably comprise from 50 to 90%, preferably from 60 to 80% water by weight of the total shampoo composition.
- Shampoo compositions for use in the invention will typically comprise one or anionic surfactants such as sodium laureth sulfate, sodium oleyl succinate, ammonium lauryl sulfosuccinate, ammonium lauryl sulphate, sodium dodecylbenzene sulphonate, triethanolamine dodecylbenzene sulfonate, sodium cocoyl isethionate, sodium lauryl isethionate, sodium N-lauryl sarcosinate, sodium lauryl sulfate, sodium lauryl ether sulfate (n) EO, (where n ranges from 1 to 3), ammonium lauryl sulfate and ammonium lauryl ether sulfate (n) EO, (where n ranges from 1 to 3) .
- anionic surfactants such as sodium laureth sulfate, sodium oleyl succinate, ammonium lauryl sulfosuccinate,
- the total amount of anionic surfactant in shampoo compositions for use in the invention generally ranges from 5 to 30%, preferably from 8 to 20% by weight of the total weight of the composition.
- Shampoo compositions for use in the invention may also include co-surfactants such as nonionic surfactants, which can be included in an amount ranging from 0.5 to 8%, preferably from 2 to 5% (by weight based on the total weight of the composition) and/or amphoteric or zwitterionic surfactants, which can be included in an amount ranging from 0.5 to 8%, preferably from 1 to 4% by weight based on the total weight of the composition.
- Representative nonionic surfactants include alkanolamides such as cocamide monoethanolamide and cocamide monoisopropanolamide; alkyl polyglucosides such as cocoglucoside and lauryl glucoside; and acyl glucamides such as cocoyl methyl glucamide.
- Representive amphoteric surfactant includes cocamidopropyl betaine. It is more preferred that the shampoo composition for use in the invention comprises sodium laureth sulfate and co-surfactant which is cocamidopropyl
- Shampoo compositions for use in the invention may also include one or more cationic polymers, which can be included in an amount ranging from 0.01 to 5%, preferably from 0.05 to 2% by weight based on the total weight of the composition.
- Representative cationic polymers include cationic polysaccharide polymers such as cationic cellulose derivatives and cationic guar gum derivatives such as guar hydroxypropyltrimethylammonium chloride.
- Shampoo compositions for use in the invention may also include one or more suspending agents, which can be included in an amount ranging from 0.05 to 5%, preferably from 0.1 to 3% (by weight based on the total weight of the composition).
- suspending agents include polyacrylic acids, cross-linked polymers of acrylic acid, copolymers of acrylic acid with a hydrophobic monomer, copolymers of carboxylic acid-containing monomers and acrylic esters, cross-linked copolymers of acrylic acid and acrylate esters, heteropolysaccharide gums and crystalline long chain acyl derivatives such as ethylene glycol distearate.
- the shampoo composition further preferably comprises a suspending agent.
- Suitable suspending agents are polyacrylic acids, cross-linked polymers of acrylic acid, copolymers of acrylic acid with a hydrophobic monomer, copolymers of carboxylic acid- containing monomers and acrylic esters, cross-linked copolymers of acrylic acid and acrylate esters, heteropolysaccharide gums and crystalline long chain acyl derivatives.
- the long chain acyl derivative is desirably selected from ethylene glycol stearate, alkanolamides of fatty acids having from 16 to 22 carbon atoms and mixtures thereof. Ethylene glycol distearate and polyethylene glycol distearate are preferred long chain acyl derivatives, since these impart pearlescence to the composition.
- Polyacrylic acid is available commercially as Carbopol® 420, Carbopol® 488 or Carbopol® 493. Polymers of acrylic acid cross-linked with a polyfunctional agent may also be used; they are available commercially as Carbopol® 910, Carbopol® 934, Carbopol® 941 and Carbopol® 980.
- Suitable cross-linked polymers of acrylic acid and acrylate esters are Pemulen® TR1 and Pemulen® TR2.
- a suitable hetero polysaccharide gum is xanthan gum, for example that available as Kelzan.
- the shampoo formulations are prepared as below in Table 1.
- a clinical study was conduction where a group of subjects who were classified as suffering with dandruff and a group of subjects who have healthy scalp were treated for 4 weeks with a shampoo containing Octopirox ® .
- Alpha diversity and beta diversity are commonly used to describe the diversity of microbiome within samples (alpha) and among samples (beta) respectively.
- the alpha diversity was assessed by the Chaol Index.
- the observations in Table 1 indicate that alpha diversity was lower in dandruff as compared to the healthy scalp microbiome (P ⁇ 0.05).
- the Chaol Index significantly increased and thereby restored to a level normally indicative of healthy scalp (there was no difference between the levels of Chaol diversity between treated dandruff subjects and healthy subjects p>0.5)
- Beta Diversity of bacteria was examined using Unweighted Unifrac metric.
- the beta diversity of bacteria of dandruff subjects is moved closer to that of the healthy scalp subjects (Refer Figure 1).
- the shift in the microbial profiles suggests that the shampoo composition restored diversity of microbiota of skin (dandruff scalp) to a level normally indicative of healthy skin.
- Beta Diversity of fungi was examined using Bray Curtis metric. As illustrated in Figure 2, a significant dissimilarity was observed between the healthy scalp and dandruff subjects (FDR ⁇ 0.05) using the Bray Curtis metric on fungal data..
- the beta diversity of fungi of dandruff subjects is moved closer to that of the healthy scalp subjects (Refer Figure 2).
- the shift in the microbial profiles suggests that the shampoo composition restored diversity of microbiota of skin (dandruff scalp) to a level normally indicative of healthy skin.
- a shampoo composition comprising piroctone olamine is found to restore the microbiome diversity in dandruff scalp via increasing the alpha diversity of the microbiome, which was lower prior to treatment compared to healthy scalp. Meanwhile, it is found to restore the microbiome diversity in dandruff scalp via restoring the beta diversity of microbiota of dandruff scalp to a level normally indicative of healthy skin.
Abstract
The present invention relates to use of a piroctone compound in a topical composition for restoring diversity of microbiota of scalp having dandruff to a level normally indicative of healthy scalp; the richness of microbes of scalp having dandruff after restoring is improved to a level normally indicated of healthy scalp.
Description
TOPICAL COMPOSITION FOR RESTORING MICROBIAL DIVERSITY OF SCALP
Field of the Invention
The present invention relates to a method of restoring microbial diversity of scalp, which is dandruff scalp.
Background of the Invention
The skin is the largest organ of human body. It protects our body from external factors such as the environment, pollution and microbes. Our skin harbours a diverse range of microorganisms which live as a community and function as a component of skin biology. Due to the advent of next-generation sequencing technologies, we now know that the microbiome or microbiota of human skin is highly dependent on biophysical characteristics and chemical constitution of the skin. For example, sebaceous sites are dominated by Cutibacterium sp., whereas moist areas harbour Staphylococcus and Corynebacterium species. Any adverse alteration in the microbiome of our skin (dysbiosis) could lead to conditions, that may need at least cosmetic treatment as such seen in the case of acne, dry skin and dandruff.
Dandruff, a skin disorder common among many people globally. The condition is manifested by the shedding of clumps of dead skin cells from the scalp. It is known that microbiome dysbiosis, increased sebum production and inflammation are the most common contributing factors. The major fungal/bacterial species present on the scalp, namely Malassezia restricta, Malassezia globosa, Cutibacterium acnes,
Staphylococcus epidermidis and Staphylococcus capitis. Staphylococcus is one of the most abundant genera across both healthy and dandruff scalps. However, at species level, Staphylococcus capitis is reported to be positively associated with dandruff conditions, while Staphylococcus epidermidis is positively associated with non-dandruff scalp conditions.
Recent studies reveal that dandruff is associated with an altered microbiota involving multiple taxa, as evidenced by an increase in the abundance of certain microbes and a concomitant decrease in the abundance of some others. Such an imbalance often manifests itself as a dysbiotic condition like acne or dandruff. Other such dysbiotic conditions include atopic dermatitis and dry skin. To some extent, such conditions can
be managed by cosmetic treatment by the application of topical compositions that contain one or more active ingredients.
The microbiome of skin can be balanced e.g. by reducing the overall microbial load of skin or by selectively reducing some while selectively increasing the count of some others.
In some cases, balancing the microbiota of skin refers to selectively increasing the microbial count of good microbes and/or reducing the same count of bad microbes. Good microbes are said to provide benefit to their host through e.g., competing with bad microbes for available nutrients and through secretion of good metabolites.
A bacterial/fungal community is characterized by the number of species present therein and their absolute numbers. This is called bacterial/fungal diversity. In order to compare the bacteria/fungal diversity of microorganisms, a variety of tools have been developed. Shannon-Weaver (or simply Shannon) and Simpson’s diversity index are commonly used in such measurements based on Operational Taxonomic Units (OTUs). OTUs can be defined at different levels of resolution such as phylum, class, order, family, genus, and species). ACE (Abundance-based Coverage Estimator) and Chaol indices are used to estimate richness (estimated richness; measurement of OTUs expected in samples given all the bacterial species that were identified in the samples).
Biological diversity means the variability among living organisms from the ecological complexes of which organisms are part, and it is defined as species richness and relative species abundance in space and time.
A measure of the number of different kinds of organisms present in a community is defined as richness, therefore richness refers to the number of different species present in a certain niche. If more species are present in “A” than “B”, “A” is richer than “B”. When it comes to species richness, it does not consider the number of individuals of each species present. Diversity is not only based on richness, but also evenness. Evenness compares the uniformity of the population size of each of the species present. A measure of the relative abundance of the different species consisting of a
community is evenness. In general, when species richness and evenness increase, diversity also increases.
XP055874533 discloses anti-dandruff composition comprising piroctone olamine as active agent against dandruff and for fighting microorganisms causing dandruff. However, it does not disclose the impact of piroctone olamine on the diversity of microbiota of scalp.
EP3695825 A1 (Unilever) discloses a hair care composition against dandruff comprising piroctone olamine. It discloses that piroctone olamine is able to decrease the level of Malassezia species. However, it does not disclose the impact of piroctone olamine on the diversity of microbiota of scalp.
WO2013093823 A2 (VYOME BIOSCIENCES PVT LTD) discloses oil compositions comprising at least 0.01wt% piroctone olamine exhibiting antifungal activity against Malassezia furfur useful as anti-dandruff agent. However, it does not disclose the impact of piroctone olamine on the diversity of microbiota of scalp.
US2016058775 A1 (PRASAD SUDHANAND ET AL) discloses hair care compositions comprising at least 0.01% of piroctone olamine exhibiting antifungal (Malassezia species) and antibacterial activity. However, it does not disclose the impact of piroctone olamine on the diversity of microbiota of scalp.
JPH10265408 A (LION CORP) discloses a lotion for atopic dermatitis comprising at least 0.01 % of a piroctone compound. However, it does not disclose the impact of piroctone olamine on the diversity of microbiota of scalp.
US10071103 B2(VYOME BIOSCIENCES PVT LTD) relates generally to novel molecules compositions and formulations for treatment of bacterial infections in general and more specifically to bacterial infections with antibiotic-tolerant pathogens. It does not disclose the use of piroctone compound for restoring diversity of microbiota of dandruff scalp.
US2019000734 A1 (STURGIS DAVID ARTHUR ET AL) relates to antiperspirant and deodorant compositions and methods relating thereto. It does not disclose the use of piroctone compound for restoring diversity of microbiota of dandruff scalp. Summary of the Invention
In accordance with a first aspect disclosed is use of a piroctone compound in a topical composition for restoring diversity of microbiota of scalp having dandruff to a level normally indicative of healthy scalp; further wherein the richness of microbes of scalp having dandruff after restoring is improved to a level normally indicated of healthy scalp.
In accordance with a second aspect of the invention disclosed is a method of restoring diversity of microbiota of scalp having dandruff to a level normally indicative of healthy scalp; further wherein the richness of microbes of scalp having dandruff after restoring is improved to a level normally indicated of healthy scalp comprising a step of applying thereto a piroctone compound in a topical composition.
In accordance with a third aspect disclosed is a topical composition comprising a piroctone compound for use in restoring diversity of microbiota of scalp having dandruff to a level normally indicative of healthy scalp; further wherein the richness of microbes of scalp having dandruff after restoring is improved to a level normally indicated of healthy scalp.
In accordance with a fourth aspect disclosed is use of a piroctone compound for restoring diversity of microbiota of scalp having dandruff to a level normally indicative of healthy scalp; further wherein the richness of microbes of scalp having dandruff after restoring is improved to a level normally indicated of healthy scalp.
Brief Description of the figures Figure 1 shows the Beta diversity of bacteria of dandruff-subjects as compared to non dandruff subjects before and after treatment.
Figure 2 shows the Beta diversity of fungi of dandruff-subjects as compared to non dandruff subjects before and after treatment.
Detailed Description of the Invention
Any feature of one aspect of the present invention may be utilized in any other aspect of the invention. The word “comprising” is intended to mean “including” but not necessarily “consisting of’ or “composed of.” In other words, the listed steps or options need not be exhaustive. Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material or conditions of reaction, physical properties of materials and/or use are to be understood as modified by the word “about”. Numerical ranges expressed in the format "x to y" are understood to include x and y. When for a specific feature multiple preferred ranges are described in the format "x to y", it is understood that all ranges combining the different endpoints are also contemplated. Unless specified otherwise, amounts as used herein are expressed in percentage by weight based on total weight of the composition and is abbreviated as “wt%”. The use of any and all examples or exemplary language e.g. “such as” provided herein is intended merely to better illuminate the invention and does not in any way limit the scope of the invention otherwise claimed.
By ‘a cosmetic composition’ as used herein, is meant to include a composition for topical application to skin, hair and/or scalp of mammals, especially human beings. Such a composition is generally applied on to the desired topical surface of the body for a period of time from a few seconds to up to 24 hours. When the period of time of application is low say of the order of a few seconds to a few minutes after which the composition is rinsed off with water or wiped away, such a composition is known as a cleansing composition or a wash-off composition. On the other hand, When the composition is applied for longer period of time say from several minutes to up to 24 hours and washed off usually during the process of normal personal cleaning, such a composition is known as a leave-on composition. The composition as per the present invention includes any product applied to a human body for also improving appearance, cleansing, odor control or general aesthetics.
By "hair care composition" as used herein, is meant to include a composition for topical application to hair or scalp of mammals, especially humans. By topical is meant that the composition is applied to the external surface of the body. In the present invention this is achieved by applying the composition on the hair or scalp. Such a composition may be generally classified as leave-on or rinse off, and includes any product applied
for improving the appearance, cleansing, odor control or general aesthetics of scalp and hair. The hair care composition of the present invention could be in the form of a liquid, lotion, cream, foam, scrub, gel, shampoo, conditioner, shower gel or bar. The haircare composition of the present invention is preferably a leave-on composition. Alternatively, the hair care composition of the present invention is a wash-off composition. Compositions for achieving the desired benefits by way of ingestion into the human body are excluded from the scope of the present invention.
Restoring the microbiota diversity used herein preferably means restoring the alpha diversity of microbiota which means increasing or decreasing the number of different types of microbes and/or the evenness of the different types of microbes in the microbiota of a subject. In some embodiments, the microbiota diversity is increased. In some embodiments, the number of different genera of bacteria in the microbiota is increased. In some embodiments, the number of different species of bacteria in the microbiota is increased. In some embodiments, the number of different strains of bacteria in the microbiota is increased. In some embodiments, the microbiota diversity is decreased. In some embodiments, the number of different genera of bacteria in the microbiota is decreased. In some embodiments, the number of different species of bacteria in the microbiota is decreased. In some embodiments, the number of different strains of bacteria in the microbiota is decreased. In some embodiments, the number of genera, species and strains in the microbiota is restored.
Restoring the microbiota diversity used herein alternatively means restoring the beta diversity of microbiota which means the similarity of a community of microbes in the microbiota of a subject. Beta diversity is a measure of the difference in microbial composition between two samples or groups of samples based on taxonomic abundance, presence or absence, or on phylogenetic distances. Samples or groups of samples that are similar to each other have a low variation in beta diversity where samples or groups of samples that are different to each other have high variation in beta diversity.
“Amenable skin” means scalp which has dandruff.
Wherein the term “normal healthy skin” preferably refers to skin which is free from any infection. Wherein the term” healthy scalp” preferably refers to scalp which is free from dandruff. Chad is Abundance-based estimator of species richness
where F1 and F2 are the count of singletons and doubletons, respectively, and Sobs is the number of observed species.
Chad is a nonparametric method for estimating the number of species in a community. The Chad richness estimator was developed by Anne Chao and is based on the concept that rare species infer the most information about the number of missing species. Because the Chad richness estimator gives more weight to the low abundance species, only the singletons and doubletons are used to estimate the number of missing species. Therefore, this index is particularly useful for data sets skewed toward the low-abundance species.
A microbe can be described as a tiny living organism, such as bacterium, fungus, or virus. A microbiome or microbiota refers collectively to all the microbes on or in the human body. In other words, a microbiome is a community of microbes. A balanced microbiota containing an appropriate diversity of organisms helps to maintain health and is essential for human development, immunity, health and wellbeing. Each of our individual microbiomes adapts throughout our lifetime and people can achieve a healthy microbiome in different ways. lAmenable skin means the scalp having dandruff.
Dandruff is a common scalp condition, characterized by excessive flaking and itch. It is generally accepted that the presence of dandruff is associated with changes in microbe ecology, altered lipid composition, inflammation and abnormal epidermal barrier function. The Malassezia yeast has long been considered as one of the main microbial
drivers for dandruff. Severity of dandruff is generally associated with an increased abundance of Malassezia restricta. In addition, a trend towards an increase in the relative proportions of Staphylococcus to Cutibacterium is observed as dandruff scores increase, suggesting an imbalanced microbial ecology in the dandruff-affected scalp.
In accordance with the present invention, it is preferred that the microbes are bacteria or fungi, more preferably bacteria. Alternatively, the microbes are protozoans or viruses. Without wishing to be bound by theory it is believed that balanced microbiota of scalp having dandruff, is a result of a piroctone compound in the topical composition with the host defense mechanism.
Diversity In accordance with one aspect of the invention, restoring diversity of microbiota of scalp having dandruff includes restoring alpha diversity, determined using an alpha diversity index. The richness of microbes of scalp having dandruff is improved to the level normally indicative of healthy scalp. Preferably the alpha diversity measures include at least one of Shannon Index, Chad, Observed OTUs, ACE, Simpson or Fisher, more preferably Chad which indicates the richness of microbes of scalp.
It is preferred that the alpha diversity index as represented by Chad index of the scalp having dandruff after restoring is increased to a level normally indicated of healthy scalp.
Alternatively, the diversity is determined using a beta diversity index. It is preferred that the beta diversity of the scalp having dandruff is restored to a level normally indicative of healthy scalp. More preferably the beta diversity measures includes Bray-Curtis dissimilarity, Jaccard distance or and weighted/unweighted UniFrac.
The Composition
It is preferred that the topical composition comprises 0.001 to 5.0 wt% of a piroctone compound.
When the composition comprises a piroctone compound, it preferably comprises 0.01 to 5%, more preferably 0.05 to 2%, still more preferably 0.5 to 1% of piroctone compound by weight of the total composition. It is preferred that the piroctone compound is piroctone olamine.
Piroctone Olamine is an olamine salt of the hydroxamic acid derivative piroctone. It is commonly known as piroctone ethanolamine with the trade name Octopirox®. The piroctone olamine according to the present invention is a 1:1 compound of 1- hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2(1H)-pyridinone with 2-aminoethanol and is also designated 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2(1H) pyridinone monoethanolamine salt. The CAS number is 68890-66-4 and the compound has the general formula (II) as below:
When the composition comprises piroctone olamine it preferably comprises 0.01 to 5%, more preferably 0.05 to 2%, still more preferably 0.5 to 1% of piroctone olamine by weight of the total composition.
It is preferred that the topical composition is a cosmetic composition. Alternatively, the topical composition is a medicament or a pharmaceutical composition.
The cosmetic composition is preferably in the form of a wash-off or a leave-on composition, more preferably a wash-off composition. Alternatively, it is a wash-off
cosmetic composition, more preferably a hair care composition comprising 0.01 to 5.0 wt% of a piroctone compound.
Leave-on composition preferably means a composition which is not required to be removed or washed off from the human body after the application of the composition. When the composition is in the form of a leave-on composition, the composition is preferably a deodorant (stick, roll-on or spray), a hand sanitizer, a body lotion, a skin cream or body spray. Leave-on compositions are to be distinguished from compositions which are applied to the skin and subsequently removed, either by washing, rinsing, wiping, or the like either soon after or during the application of the product. Surfactants typically used for rinse-off compositions have physico-chemical properties giving them the ability to generate foam/lather in-use with ease of rinse; they can consist of mixtures of anionic, cationic, amphoteric, and nonionic surfactants. Wash-off composition preferably means a composition which is intended/required to be removed from the body by washing with solvent preferably water after the application of said composition like e.g. a shampoo, a hand wash composition and a face wash composition. In case of wash-off compositions, a cosmetically acceptable base preferably further comprises a surfactant.
For example, if the composition is in the form of a shampoo, in addition to water, the cosmetically acceptable base preferably comprises an anionic surfactant e.g. an alkyl sulphate and/or ethoxylated alkyl sulfate surfactant. These anionic surfactants are preferably present at a level of from 1 to 20 wt%, more preferably from 2 to 16 wt%, even more preferably from 3 to 16 wt%. Preferred alkyl sulfates are C8 to 18 alkyl sulfates, more preferably C12 to 18 alkyl sulfates, preferably in the form of a salt with a solubilizing cation such as sodium, potassium, ammonium or substituted ammonium.
It is preferred that the topical composition comprises a cosmetically acceptable base. Examples of ingredients that may be used as cosmetically acceptable base includes water, fatty acids, soaps (salts of fatty acids), alcohols and mixtures thereof.
When the composition for use in the invention is a hair care composition, it preferably is a wash-off composition, especially shampoo or a conditioner.
The preferred use of the cosmetic composition is in a shampoo. The cosmetic composition may suitably comprise from 50 to 90%, preferably from 60 to 80% water by weight of the total shampoo composition. Shampoo compositions for use in the invention will typically comprise one or anionic surfactants such as sodium laureth sulfate, sodium oleyl succinate, ammonium lauryl sulfosuccinate, ammonium lauryl sulphate, sodium dodecylbenzene sulphonate, triethanolamine dodecylbenzene sulfonate, sodium cocoyl isethionate, sodium lauryl isethionate, sodium N-lauryl sarcosinate, sodium lauryl sulfate, sodium lauryl ether sulfate (n) EO, (where n ranges from 1 to 3), ammonium lauryl sulfate and ammonium lauryl ether sulfate (n) EO, (where n ranges from 1 to 3) .
Mixtures of any of the above described materials may also be used. The total amount of anionic surfactant in shampoo compositions for use in the invention generally ranges from 5 to 30%, preferably from 8 to 20% by weight of the total weight of the composition.
Shampoo compositions for use in the invention may also include co-surfactants such as nonionic surfactants, which can be included in an amount ranging from 0.5 to 8%, preferably from 2 to 5% (by weight based on the total weight of the composition) and/or amphoteric or zwitterionic surfactants, which can be included in an amount ranging from 0.5 to 8%, preferably from 1 to 4% by weight based on the total weight of the composition. Representative nonionic surfactants include alkanolamides such as cocamide monoethanolamide and cocamide monoisopropanolamide; alkyl polyglucosides such as cocoglucoside and lauryl glucoside; and acyl glucamides such as cocoyl methyl glucamide. Representive amphoteric surfactant includes cocamidopropyl betaine. It is more preferred that the shampoo composition for use in the invention comprises sodium laureth sulfate and co-surfactant which is cocamidopropyl betaine.
Mixtures of any of the above described materials may also be used.
Shampoo compositions for use in the invention may also include one or more cationic polymers, which can be included in an amount ranging from 0.01 to 5%, preferably from 0.05 to 2% by weight based on the total weight of the composition. Representative cationic polymers include cationic polysaccharide polymers such as cationic cellulose derivatives and cationic guar gum derivatives such as guar hydroxypropyltrimethylammonium chloride.
Shampoo compositions for use in the invention may also include one or more suspending agents, which can be included in an amount ranging from 0.05 to 5%, preferably from 0.1 to 3% (by weight based on the total weight of the composition). Representative suspending agents include polyacrylic acids, cross-linked polymers of acrylic acid, copolymers of acrylic acid with a hydrophobic monomer, copolymers of carboxylic acid-containing monomers and acrylic esters, cross-linked copolymers of acrylic acid and acrylate esters, heteropolysaccharide gums and crystalline long chain acyl derivatives such as ethylene glycol distearate.
The shampoo composition further preferably comprises a suspending agent. Suitable suspending agents are polyacrylic acids, cross-linked polymers of acrylic acid, copolymers of acrylic acid with a hydrophobic monomer, copolymers of carboxylic acid- containing monomers and acrylic esters, cross-linked copolymers of acrylic acid and acrylate esters, heteropolysaccharide gums and crystalline long chain acyl derivatives. The long chain acyl derivative is desirably selected from ethylene glycol stearate, alkanolamides of fatty acids having from 16 to 22 carbon atoms and mixtures thereof. Ethylene glycol distearate and polyethylene glycol distearate are preferred long chain acyl derivatives, since these impart pearlescence to the composition. Polyacrylic acid is available commercially as Carbopol® 420, Carbopol® 488 or Carbopol® 493. Polymers of acrylic acid cross-linked with a polyfunctional agent may also be used; they are available commercially as Carbopol® 910, Carbopol® 934, Carbopol® 941 and Carbopol® 980.
Suitable cross-linked polymers of acrylic acid and acrylate esters are Pemulen® TR1 and Pemulen® TR2. A suitable hetero polysaccharide gum is xanthan gum, for example that available as Kelzan.
The present invention now will be demonstrated by way of following non-limiting examples.
Examples
Example 1
These examples are to explore the effect of a prototype shampoo with Octopirox® on scalp microbiome through investigation of both scalp fungal and bacterial communities of dandruff scalp and healthy scalp.
The shampoo formulations are prepared as below in Table 1.
A clinical study was conduction where a group of subjects who were classified as suffering with dandruff and a group of subjects who have healthy scalp were treated for 4 weeks with a shampoo containing Octopirox®.
Following treatment assessment was made of changes / differences in microbiome profiles (bacteria and fungi) between the groups.
Alpha Diversity:
Chaol - An alpha diversity metric used to examine the “richness” of a sample. How many types of bacteria / fungi are present in a sample. Beta Diversity: A measure used to examine the differences in complete community composition taking into account all the organisms in the sample.
• Bray Curtis: Examines differences based on the abundance of all microbes
• Jaccard: Examines differences based presence or absence of microbes
• Unweighted Unifrac: Phylogenetics differences without using abundances measures
The observations concerning alpha diversity (Chaol Index) of bacteria are presented in Table 2. Table 2
Diversity is an important characteristic of microbiome that may be unique to different body sites. Changes in diversity of microbiota is usually an indication of dysbiosis.
Alpha diversity and beta diversity are commonly used to describe the diversity of microbiome within samples (alpha) and among samples (beta) respectively. In the present experiments, the alpha diversity was assessed by the Chaol Index. The observations in Table 1 indicate that alpha diversity was lower in dandruff as compared to the healthy scalp microbiome (P<0.05). After 4-weeks of treatment of the dandruff subjects, the Chaol Index significantly increased and thereby restored to a level normally indicative of healthy scalp (there was no difference between the levels of Chaol diversity between treated dandruff subjects and healthy subjects p>0.5)
Beta Diversity of bacteria was examined using Unweighted Unifrac metric.
As illustrated in Figure 1, a significant dissimilarity was observed between the healthy scalp and dandruff subjects (FDR<0.05) using the Unweighted Unifrac metric on bacterial data.
After 4-weeks of cosmetic treatment with the shampoo composition comprising piroctone olamine, the beta diversity of bacteria of dandruff subjects is moved closer to that of the healthy scalp subjects (Refer Figure 1). The shift in the microbial profiles suggests that the shampoo composition restored diversity of microbiota of skin (dandruff scalp) to a level normally indicative of healthy skin.
Beta Diversity of fungi was examined using Bray Curtis metric. As illustrated in Figure 2, a significant dissimilarity was observed between the healthy scalp and dandruff subjects (FDR<0.05) using the Bray Curtis metric on fungal data..
After 4-weeks of cosmetic treatment with the shampoo composition comprising piroctone olamine, the beta diversity of fungi of dandruff subjects is moved closer to that of the healthy scalp subjects (Refer Figure 2). The shift in the microbial profiles suggests that the shampoo composition restored diversity of microbiota of skin (dandruff scalp) to a level normally indicative of healthy skin.
In conclusion, a shampoo composition comprising piroctone olamine is found to restore the microbiome diversity in dandruff scalp via increasing the alpha diversity of the microbiome, which was lower prior to treatment compared to healthy scalp. Meanwhile, it is found to restore the microbiome diversity in dandruff scalp via restoring the beta diversity of microbiota of dandruff scalp to a level normally indicative of healthy skin.
Claims
1. Use of a piroctone compound in a topical composition for restoring diversity of microbiota of scalp having dandruff to a level normally indicative of healthy scalp; further wherein the richness of microbes of scalp having dandruff after restoring is improved to a level normally indicated of healthy scalp.
2. Use as claimed in claim 1 wherein said topical composition is a cosmetic composition.
3. Use as claimed in claim 1 or 2 wherein the alpha diversity index as represented by Chad index of the scalp having dandruff after restoring is increased to a level normally indicated of healthy scalp.
4. Use as claimed in any of claims 1 to 3 wherein said microbes are bacteria or fungi, preferably bacteria.
5. Use as claimed in any of claims 1 to 4 wherein the beta diversity of the scalp having dandruff is restored to a level normally indicative of healthy scalp.
6. Use as claimed in any of claims 1 to 5 wherein said composition comprises 0.01 to 5.0 wt% of said piroctone compound.
7. Use as claimed in any of the claims 1 to 6 wherein said piroctone compound is piroctone olamine.
8. A method of restoring diversity of microbiota of scalp having dandruff to a level normally indicative of healthy scalp; further wherein the richness of microbes of scalp having dandruff after restoring is improved to a level normally indicated of healthy scalp comprising a step of applying thereto piroctone compound in a topical composition.
9. A topical composition comprising piroctone compound for use in restoring diversity of microbiota of scalp having dandruff to a level normally indicative of
healthy scalp; further wherein the richness of microbes of scalp having dandruff after restoring is improved to a level normally indicated of healthy scalp.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNPCT/CN2021/099237 | 2021-06-09 | ||
CN2021099237 | 2021-06-09 | ||
EP21187097 | 2021-07-22 | ||
EP21187097.7 | 2021-07-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022258404A1 true WO2022258404A1 (en) | 2022-12-15 |
Family
ID=82067748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2022/064510 WO2022258404A1 (en) | 2021-06-09 | 2022-05-30 | Topical composition for restoring microbial diversity of scalp |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022258404A1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10265408A (en) * | 1997-03-25 | 1998-10-06 | Lion Corp | Sterilizer composition |
WO2013093823A2 (en) | 2011-12-20 | 2013-06-27 | Vyome Biosciences Pvt Ltd | Topical oil composition for the treatment of fungal infections |
US20160058775A1 (en) | 2013-04-12 | 2016-03-03 | Vyome Biosciences Pvt. Ltd. | Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections |
US10071103B2 (en) | 2014-01-29 | 2018-09-11 | Vyome Biosciennces Pvt. Ltd. | Treatments for resistant acne |
US20190000734A1 (en) | 2017-06-30 | 2019-01-03 | The Procter & Gamble Company | Antiperspirant and deodorant compositions |
EP3695825A1 (en) | 2019-02-15 | 2020-08-19 | Unilever PLC | Hair care composition |
WO2020244898A1 (en) * | 2019-06-06 | 2020-12-10 | Unilever N.V. | Topical composition for restoring microbial diversity of amenable skin |
-
2022
- 2022-05-30 WO PCT/EP2022/064510 patent/WO2022258404A1/en active Search and Examination
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10265408A (en) * | 1997-03-25 | 1998-10-06 | Lion Corp | Sterilizer composition |
WO2013093823A2 (en) | 2011-12-20 | 2013-06-27 | Vyome Biosciences Pvt Ltd | Topical oil composition for the treatment of fungal infections |
US20160058775A1 (en) | 2013-04-12 | 2016-03-03 | Vyome Biosciences Pvt. Ltd. | Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections |
US10071103B2 (en) | 2014-01-29 | 2018-09-11 | Vyome Biosciennces Pvt. Ltd. | Treatments for resistant acne |
US20190000734A1 (en) | 2017-06-30 | 2019-01-03 | The Procter & Gamble Company | Antiperspirant and deodorant compositions |
EP3695825A1 (en) | 2019-02-15 | 2020-08-19 | Unilever PLC | Hair care composition |
WO2020244898A1 (en) * | 2019-06-06 | 2020-12-10 | Unilever N.V. | Topical composition for restoring microbial diversity of amenable skin |
Non-Patent Citations (2)
Title |
---|
CAS , no. 68890-66-4 |
DATABASE GNPD [online] MINTEL; 30 May 2006 (2006-05-30), ANONYMOUS: "Anti-Dandruff Treatment", XP055874533, retrieved from https://www.gnpd.com/sinatra/recordpage/537512/ Database accession no. 537512 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110418630B (en) | Antimicrobial compositions comprising essential oils and antimicrobial lipids | |
JP6911100B2 (en) | Antibacterial composition | |
CA2486455C (en) | Skin cleanser compositions and methods of use | |
US20060074029A1 (en) | Topical antimicrobial composition having improved moisturization properties | |
WO2022152164A1 (en) | Cleaning composition having bacteriostatic effect and preservative-free cleaning product | |
JP7009444B2 (en) | Antibacterial composition | |
JP7009447B2 (en) | Antibacterial composition | |
WO2022258404A1 (en) | Topical composition for restoring microbial diversity of scalp | |
EP3723714B1 (en) | Propanediol monoacetate mononitrate | |
JP6900375B2 (en) | Hair care composition | |
WO2022258405A1 (en) | Topical composition for balancing microbiota of skin | |
JP7187544B2 (en) | antibacterial composition | |
CN110325170B (en) | Hair care composition | |
CN110545788B (en) | Antimicrobial compositions | |
WO2023107659A1 (en) | Personal care compositions | |
JP2006298891A (en) | Hair detergent composition for preventing dandruff and itch | |
JP2022542970A (en) | anti-dandruff composition | |
JP2022542971A (en) | anti-dandruff composition | |
JP2021506753A (en) | Topical composition containing antibacterial lipids | |
JP2023530138A (en) | topical antibacterial composition | |
EP4168125A1 (en) | A topical antimicrobial composition | |
EA039964B1 (en) | ANTIMICROBIAL COMPOSITION CONTAINING ESSENTIAL OIL AND ANTIMICROBIAL LIPID |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22730878 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |